1. Home
  2. HOWL vs BCG Comparison

HOWL vs BCG Comparison

Compare HOWL & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • BCG
  • Stock Information
  • Founded
  • HOWL 2017
  • BCG 2016
  • Country
  • HOWL United States
  • BCG United States
  • Employees
  • HOWL N/A
  • BCG N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • BCG
  • Sector
  • HOWL Health Care
  • BCG
  • Exchange
  • HOWL Nasdaq
  • BCG Nasdaq
  • Market Cap
  • HOWL 37.9M
  • BCG 42.3M
  • IPO Year
  • HOWL 2021
  • BCG N/A
  • Fundamental
  • Price
  • HOWL $0.87
  • BCG $2.16
  • Analyst Decision
  • HOWL Strong Buy
  • BCG
  • Analyst Count
  • HOWL 3
  • BCG 0
  • Target Price
  • HOWL $9.00
  • BCG N/A
  • AVG Volume (30 Days)
  • HOWL 232.7K
  • BCG 43.9K
  • Earning Date
  • HOWL 05-08-2025
  • BCG 05-26-2025
  • Dividend Yield
  • HOWL N/A
  • BCG N/A
  • EPS Growth
  • HOWL N/A
  • BCG N/A
  • EPS
  • HOWL N/A
  • BCG N/A
  • Revenue
  • HOWL $1,143,000.00
  • BCG $164,877,000.00
  • Revenue This Year
  • HOWL N/A
  • BCG N/A
  • Revenue Next Year
  • HOWL $733.33
  • BCG N/A
  • P/E Ratio
  • HOWL N/A
  • BCG N/A
  • Revenue Growth
  • HOWL N/A
  • BCG 1.25
  • 52 Week Low
  • HOWL $0.60
  • BCG $1.71
  • 52 Week High
  • HOWL $6.34
  • BCG $12.22
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 46.85
  • BCG N/A
  • Support Level
  • HOWL $0.80
  • BCG N/A
  • Resistance Level
  • HOWL $0.97
  • BCG N/A
  • Average True Range (ATR)
  • HOWL 0.07
  • BCG 0.00
  • MACD
  • HOWL 0.02
  • BCG 0.00
  • Stochastic Oscillator
  • HOWL 41.92
  • BCG 0.00

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About BCG Binah Capital Group Inc. Common Stock

Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.

Share on Social Networks: